Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:363-367
Published online before print January 13, 2005, doi: 10.1161/01.RES.0000156075.00127.C3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/3/363    most recent
01.RES.0000156075.00127.C3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reichelt, M. E.
Right arrow Articles by Headrick, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reichelt, M. E.
Right arrow Articles by Headrick, J. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies
Right arrow Acute myocardial infarction
Right arrow Receptor pharmacology
(Circulation Research. 2005;96:363.)
© 2005 American Heart Association, Inc.


Integrative Physiology

Genetic Deletion of the A1 Adenosine Receptor Limits Myocardial Ischemic Tolerance

Melissa E. Reichelt*, Laura Willems*, Jose G. Molina, Chun-Xiao Sun, Janci C. Noble, Kevin J. Ashton, Jurgen Schnermann, Michael R. Blackburn, John P. Headrick

From the Heart Foundation Research Center (M.E.R., L.W., K.J.A., J.P.H.), Griffith University, Southport, Australia; the Department of Biochemistry and Molecular Biology (J.G.M., C.-X.S., J.C.N., M.R.B.), University of Texas Health Science Center at Houston, Medical School, Houston; and the National Institute of Diabetes and Digestive and Kidney Diseases (J.S.), National Institutes of Health, Bethesda, Md.

Correspondence to John Headrick, Heart Foundation Research Centre, Griffith University, Southport, QLD 4217, Australia. E-mail J.Headrick{at}griffith.edu.au

Adenosine receptors may be important determinants of intrinsic ischemic tolerance. Genetically modified mice were used to examine effects of global A1 adenosine receptor (A1AR) knockout (KO) on function and ischemic tolerance in perfused mouse hearts. Baseline contractile function and heart rate were unaltered by A1AR KO, which was shown to abolish the negative chronotropic effects of 2-chloroadenosine (A1AR-mediated) without altering A2 adenosine receptor–mediated coronary dilation. Tolerance to 25 minutes global normothermic ischemia (followed by 45 minutes reperfusion) was significantly limited by A1AR KO, with impaired contractile recovery (reduced by {approx}25%) and enhanced lactate dehydrogenase (LDH) efflux (increased by {approx}100%). Functional effects of A1AR KO involved worsened systolic pressure development with little to no change in diastolic dysfunction. In contrast, cardiac specific A1AR overexpression enhanced ischemic tolerance with a primary action on diastolic dysfunction. Nonselective receptor agonism (10 µmol/L 2-chloroadenosine) protected wild-type and also A1AR KO hearts (albeit to a lesser extent), implicating protection via subtypes additional to A1ARs. However, A1AR KO abrogated effects of 2-chloroadenosine on ischemic contracture and diastolic dysfunction. These data are the first demonstrating global deletion of the A1AR limits intrinsic myocardial resistance to ischemia. Data indicate the function of intrinsically activated A1ARs appears primarily to be enhancement of postischemic contractility and limitation of cell death.


Key Words: adenosine • A1 adenosine receptor • gene knockout • ischemia • reperfusion




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Naydenova, J. B. Rose, and I. R. Coe
Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2687 - H2692.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Wee, J. N. Peart, and J. P. Headrick
P2 Purinoceptor-Mediated Cardioprotection in Ischemic-Reperfused Mouse Heart
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, L. C. Zacharia, Z. Tang, J. Zhang, L. L. Lee, J. C. Good, D. E. Herrmann, Y. Higuchi, W. J. Koch, E. K. Jackson, et al.
A1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction
Circulation, May 1, 2007; 115(17): 2307 - 2315.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick
Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine
Exp Physiol, January 1, 2007; 92(1): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al.
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function
Circulation, November 21, 2006; 114(21): 2240 - 2250.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Wakeno, T. Minamino, O. Seguchi, H. Okazaki, O. Tsukamoto, K.-i. Okada, A. Hirata, M. Fujita, H. Asanuma, J. Kim, et al.
Long-Term Stimulation of Adenosine A2b Receptors Begun After Myocardial Infarction Prevents Cardiac Remodeling in Rats
Circulation, October 31, 2006; 114(18): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Willems, M. E. Reichelt, J. G. Molina, C.-X. Sun, J. L. Chunn, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick
Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts
Cardiovasc Res, July 1, 2006; 71(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. R. Gross and G. J. Gross
Ligand triggers of classical preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 212 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. R. Lankford, J.-N. Yang, R. Rose'Meyer, B. A. French, G. P. Matherne, B. B. Fredholm, and Z. Yang
Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1469 - H1473.
[Abstract] [Full Text] [PDF]